Andy Sloan

Research Communications Manager @livuni

[CELT Global Health @CELTLiverpool]

The #LONGEVITYproject, funded by @UNITAID, is an international consortium spanning the journey from idea to manufacture of long-acting therapeutics for malaria, TB and hepatitis C virus in low- and middle- income countries where the burden is highest.
https://t.co/j7BRxbqfNR

[Research at University of Liverpool @LivUniResearch]

Today is the International Day of Human Space flight.🚀
Explore the amazing space engineering research @livuni that is helping to discover new ways to protect our planet and the wider universe.
WATCH: https://t.co/RsrbHM5Z3D 📽️

[Andy Sloan @Andy_Sloan_]

@LivUniAlumni

[Research at University of Liverpool @LivUniResearch]

🌍🩺 We're actively investing in research-based solutions that safeguard lives, livelihoods, and promote community resilience for a stable, healthy future.💙 #Health #Relief #Recovery #Peace #TeamLivUni #COP28

➡️ https://t.co/1lnAdGLi0r

🧵 1/4

[Research at University of Liverpool @LivUniResearch]

It’s today! Really looking forward to a lively discussion at 5pm with @sjyates @GoodThingsFdn , @MetroMayorSteve @Cwmpas_Coop @smartlyte @VMO2News @tobyperkinsmp @JenWilliams_FT and @GMCAdigital. #FixtheDigitalDivide

@N8research @theRSAorg @GrowthPlatform_

[Research at University of Liverpool @LivUniResearch]

We're looking forward to our #UPNorth event with @N8research @theRSAorg at @UKLabour
conference next Monday! We're also delighted to have @tobyperkinsmp join our brilliant panel chaired by @JenWilliams_FT to discuss living standards & what we can do to support digital inclusion

[Research at University of Liverpool @LivUniResearch]

“Antimicrobials underpin safe and functioning prosperous societies, so collaboration must be at the heart of everything we do.” Prof William Hope, Prof Alison Holmes and Dr Ishwar Singh talk to @timeshighered about combating #AMR

🎙️Listen to the podcast

https://t.co/C2Opnk0lg6

[CELT Global Health @CELTLiverpool]

We're recruiting for a Science Communications Officer. The deadline for our vacancy is 11th August!

✅Lead engagement activities and external communication strategies
✅Support public engagement participation activities

Click below for more details 👇
https://t.co/Xy8aRjqJ77

[CELT Global Health @CELTLiverpool]

The #LONGEVITYProject will deploy a #longacting injectable to provide protection from malaria with just one injection a year.
Our aim is to
✅Simplify drug delivery
✅Improve adherence
✅Reduce transmission
Find out more 👉https://t.co/iVOMIr31vx

[CELT Global Health @CELTLiverpool]

If you want to know more about how we use #MathematicalModelling, we discuss data analysis, modelling and accelerating the development of #longacting therapeutics in our latest blog! #DevelopingTheLongActingPipeline

https://t.co/BvpUuWVnOa

[Andy Sloan @Andy_Sloan_]

Fantastic news, congratulations @aeolagunju!

[University of Liverpool News @livuninews]

A @LivUni researcher, Dr Adeniyi Olagunju has been awarded a highly competitive fellowship, the @wellcometrust Career Development Award.

The £1.68m will allow Dr Olagunju to continue his research into drug safety in pregnancy.

Read more here https://t.co/dwL56MnGFJ

[CELT Global Health @CELTLiverpool]

If you work in the field of #nanotherapeutics or have a related #nanomedicine project, you could benefit from the analytical expertise and links to partner institutions of CELT's #NanotherapeuticsHub.

Find out about the NTH and how we can help you👉 https://t.co/AKfZgEL3LX

[Research at University of Liverpool @LivUniResearch]

Today is #ShowYourStripes day!

We are displaying Liverpool's #WarmingStripes at The Museum of Liverpool to raise awareness of rising global temperatures.

These stripes show the rising average temperature in Liverpool since 1850.

Find out more👇
https://t.co/hWTSBQm4NQ

[CELT Global Health @CELTLiverpool]

Through the #LONGEVITYProject we aim to develop a single-injection cure for #HepC to be deployed in low- and middle-income countries.

With our revolutionary technology, we can eliminate pill burden, stigma and issues around complex delivery modes.

👉https://t.co/Scai2brB0p

[CELT Global Health @CELTLiverpool]

The #LONGEVITYProject strategy is to repurpose pre-existing oral medicines as #longacting formulations. This is made possible by our patented SDN technology, developed by CELT scientists.

Find out about how our technology works
👉https://t.co/9aO3TJY0rB

#nanoparticles #nanotech

[CELT Global Health @CELTLiverpool]

Read our interview with Dorothy Onyango of the #longacting Technologies Community Advisory Board and find out how her work in #malaria endemic communities is helping shape our #LONVEVITYProject development programme.

👉https://t.co/bYxSatoBW9

[CELT Global Health @CELTLiverpool]

The #LONGEVITYProject aims to deploy new #longacting medicines in #LMICs for #Malaria, #TB and #HepatitisC in #LMICs. It is here where the burden is highest, with an estimated 300 million people infected and more than two million deaths per year.

👉https://t.co/j7BRxbqfNR

[CELT Global Health @CELTLiverpool]

The #HepatitisC burden in low- and middle-income countries
➡️43 million existing cases
➡️1.5 million new cases a year
➡️Poor access to diagnosis and treatment
➡️Oral regimens are hard to maintain

Learn how we can revolutionise #HepC healthcare for #LMICs👉https://t.co/Scai2br3aR

[CELT Global Health @CELTLiverpool]

Through the #LONGEVITYProject we can;

✅Reduce the burden of unsustainable oral regimens
✅Transform healthcare programmes
✅Improve the quality of care for millions of people.

Find out about our strategies for #Malaria, #TB and #HepatitisC in #LMICs

👉https://t.co/j7BRxbqNDp

[CELT Global Health @CELTLiverpool]

The #LONGEVITY project aims to revolutionise healthcare in LMICs. With #longacting medicines, we can reduce the burden of #Malaria, #TB, and #HepatitisC.

Find out about our objectives👇
https://t.co/C0SitsY7Jx

Funded by @UNITAID